Just last week national allergy organizations sent announcements to providers to make them aware that a generic version of the Adrenaclick® auto injector is being marketed under the name epinephrine injection, USP auto-injector. Adrenaclick® was a 2.0 version of the Twinject® device without the second dose inside. The availability of this generic version of Adrenaclick® could result in substitutions of other autoinjectors at the pharmacy. This is not a generic version of the EpiPen® or Auvi-Q® devices. It is important for patients and caregivers to receive the injectable epinephrine device on which they have been trained to minimize confusion, which could lead to a delay or an error in administering the drug.
Before leaving the pharmacy, make sure you have received the appropriate device. Further information and instructions for administration can be found at the following websites:
Be sure to subscribe to receive updates by email (scroll up and hit the “Follow” button on the right)? Please “like” my facebook page at www.facebook.com/drdamin, follow me on Twitter and share this page with other allergy sufferers.
Disclaimer: This blog is not intended to create a doctor-patient relationship with any reader. If you need personalized medical advice, contact your primary care physician or other physician in your community.